Both in Biotechnology
BioCryst Pharmaceuticals vs Vericel
Over the past year BCRX returned +9.7% and VCEL returned +27.6%; their daily moves had a correlation of 0.09.
BCRX +9.7% VCEL +27.6%Growth of $1, one year, split-adjusted
| Metric | BCRX | VCEL |
|---|---|---|
| Price | $8.33 | $40.14 |
| Market cap | $2.13B | $2.06B |
| Today | +0.73% | −1.16% |
| 1 month | −14.1% | +0.6% |
| 6 months | −12.5% | +24.8% |
| Year to date | +6.8% | +11.5% |
| 1 year | +10.3% | +26.3% |
| Revenue growth (YoY) | +33.6% | +22.5% |
| Gross margin | 98.2% | 72.8% |
| Net margin | 35.9% | 2.8% |
| P/E (TTM) | — | 84.9× |
| Price / sales | 2.3× | 6.7× |
| Net cash | -$471.6M | $162.5M |
| Dividend yield | — | — |
| Volatility (60d) | 45.0% | 28.8% |
| Short % of float | 17.5% | 11.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).